Bio Medica Laboratories IPO
Price Band
₹132 – ₹139
Issue Size
₹52.43 Cr
Lot Size
1000 shares
Min ₹2,78,000
Issue Dates
21 May – 25 May 2026
Listing Date
29 May 2026
About Bio Medica Laboratories Ltd
Bio Medica Laboratories Ltd is an India-based pharmaceutical manufacturing company specializing in parenteral formulations including liquid injectables and dry powder injectables for human and veterinary healthcare. The company operates on a B2B contract manufacturing model and offers ethical drugs, generic medicines, and OTC pharmaceutical products. It operates two manufacturing facilities in Indore, Madhya Pradesh and is certified for GMP and GLP compliance.
Visit WebsiteIPO Details
| Price Band | ₹132 – ₹139 |
| Face Value | ₹10 |
| Lot Size | 1000 shares(Min ₹2,78,000) |
| Issue Size | ₹52.43 Cr |
| Fresh Issue | ₹47.19 Cr |
| Offer for Sale | ₹5.24 Cr |
| Total Shares Offered | 37,72,000 |
| Listed On | NSE |
Objects of the Issue
Repayment of loan, enhancement of existing production capabilities by setting up a new manufacturing facility, and general corporate purposes
Key Financial Metrics
EPS (Basic)
₹10.67
P/E Ratio
13.03x
ROE
54.41%
ROCE
23.22%
Debt / Equity
2.23
Financial Performance
| Particulars (₹ Cr) | FY23 | FY24 | FY25 |
|---|---|---|---|
| Revenue | 16.25 | 15.34 | 38.33 |
| EBITDA | 1.7 | 5.63 | 15.21 |
| PAT | 0.33 | 2.5 | 9.79 |
| Total Assets | 17.57 | 19.53 | 39.12 |
| Net Worth | 2.44 | 4.94 | 14.73 |
| Total Borrowings | 9.61 | 10.49 | 15.01 |
Valuation
Market Capitalisation
P/E Ratio
Promoter Holding
Public Holding
Lot Size & Allocation
Investment by Category
| Category | Lot Size | Min Investment | Max Investment |
|---|---|---|---|
| Retail (RII) | 2 × 1000 | ₹2,78,000 | ₹2,78,000 |
| S-HNI | 3 × 1000 | ₹4,17,000 | ₹9,73,000 |
| B-HNI | 8 × 1000 | ₹11,12,000 | — |
| QIB | 1000 shares | — | — |
Reservation / Allocation
| Category | Allocation | Cut-off |
|---|---|---|
| QIB (Qualified Institutional Buyers) | 1% | No |
| RII (Retail Individual Investors) | 50.01% | No |
| NII (Non-Institutional Investors) | 48.98% | No |
Registrar & Lead Managers
Registrar
Lead Managers (1)
Peer Comparison
| Company | Listed | Mkt Cap (₹ Cr) | EPS (₹) | P/E | ROE % |
|---|---|---|---|---|---|
| Bio Medica Laboratories IPO (this IPO) | — | 226 | ₹10.67 | 13.03x | 54.41% |
| Bio Medica Laboratories Ltd | No | 174.79 | ₹10.67 | 13.03x | 54.41% |
| Nephrocare Health Services Ltd (NephroPlus - unlisted peer) | No | 1,200 | ₹18.4 | 28.5x | 22.1% |
| SMS Pharmaceuticals Ltd | Yes | 3,200 | ₹22.15 | 24.3x | 16.9% |
| Sequent Scientific Ltd | Yes | 2,900 | ₹6.8 | 35.2x | 9.4% |
| Neuland Laboratories Ltd | Yes | 18,000 | ₹140.25 | 38.1x | 24.6% |
Data as of 31/3/2025
Important Dates
Community Discussion
Ask questions and share your thoughts about this IPO
Be the first to ask or share about Bio Medica Laboratories IPO